HK1101555A1 - Composition comprising protein material and non-oxidizable fatty acid entities - Google Patents
Composition comprising protein material and non-oxidizable fatty acid entitiesInfo
- Publication number
- HK1101555A1 HK1101555A1 HK07109601.5A HK07109601A HK1101555A1 HK 1101555 A1 HK1101555 A1 HK 1101555A1 HK 07109601 A HK07109601 A HK 07109601A HK 1101555 A1 HK1101555 A1 HK 1101555A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein material
- composition
- stenosis
- fatty acid
- acid entities
- Prior art date
Links
- 239000000463 material Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 2
- 208000031481 Pathologic Constriction Diseases 0.000 abstract 2
- 230000036262 stenosis Effects 0.000 abstract 2
- 208000037804 stenosis Diseases 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000032928 Dyslipidaemia Diseases 0.000 abstract 1
- 206010048554 Endothelial dysfunction Diseases 0.000 abstract 1
- 208000004930 Fatty Liver Diseases 0.000 abstract 1
- 108010028690 Fish Proteins Proteins 0.000 abstract 1
- 206010019708 Hepatic steatosis Diseases 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 1
- 108010073771 Soybean Proteins Proteins 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000008694 endothelial dysfunction Effects 0.000 abstract 1
- 208000010706 fatty liver disease Diseases 0.000 abstract 1
- 235000021323 fish oil Nutrition 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000003805 procoagulant Substances 0.000 abstract 1
- 239000003531 protein hydrolysate Substances 0.000 abstract 1
- 108010027322 single cell proteins Proteins 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 229940001941 soy protein Drugs 0.000 abstract 1
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/04—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from fish or other sea animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Animal Husbandry (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Physiology (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20043093A NO324534B1 (no) | 2004-07-19 | 2004-07-19 | Materiale fremstilt fra en kombinasjon av ikke-β-oksiderbare fettsyreanaloger og en planteolje eller fiskeolje samt anvendelser derav |
NO20043091A NO324533B1 (no) | 2004-07-19 | 2004-07-19 | Materiale fremstilt fra en kombinasjon av ikke-β-oksiderbare fettsyreanaloger og et proteinmateriale, samt anvendelse derav. |
NO20045544A NO326252B1 (no) | 2004-12-17 | 2004-12-17 | Dyrefôr omfattende ikke-beta-oksiderbare fettsyreanaloger |
PCT/NO2005/000272 WO2006009465A2 (en) | 2004-07-19 | 2005-07-19 | Composition comprising protein material and non-oxidizable fatty acid entities |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1101555A1 true HK1101555A1 (en) | 2007-10-18 |
Family
ID=35149662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07109601.5A HK1101555A1 (en) | 2004-07-19 | 2007-09-04 | Composition comprising protein material and non-oxidizable fatty acid entities |
Country Status (13)
Country | Link |
---|---|
US (3) | US20070009608A1 (xx) |
EP (3) | EP1773397A2 (xx) |
JP (2) | JP2008506774A (xx) |
KR (2) | KR20070046866A (xx) |
AU (2) | AU2005264782B2 (xx) |
CA (2) | CA2574366A1 (xx) |
DK (1) | DK2275140T3 (xx) |
ES (1) | ES2660700T3 (xx) |
HK (1) | HK1101555A1 (xx) |
MX (2) | MX2007000813A (xx) |
NO (2) | NO20070924L (xx) |
NZ (2) | NZ553261A (xx) |
WO (2) | WO2006009464A2 (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO328803B1 (no) * | 2000-03-03 | 2010-05-18 | Thia Medica | Nye fettsyreanaloger |
DE10023486C1 (de) * | 2000-05-09 | 2002-03-14 | Schering Ag | Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel |
CA2490121C (en) * | 2002-06-20 | 2013-01-08 | Ic Vec Limited | Modified phospholipids |
DE10236146A1 (de) * | 2002-07-31 | 2004-02-19 | Basf Coatings Ag | Beschichtungsstoff, Verfahren zu seiner Herstellung und seine Verwendung |
NO20055541L (no) * | 2005-11-23 | 2007-05-24 | Berge Biomed As | Use of fatty acid analogues |
DK2117342T3 (en) * | 2007-02-08 | 2016-08-01 | Ewos Innovation As | A feed composition for salmonids and uses thereof |
US7943163B2 (en) | 2007-08-22 | 2011-05-17 | Response Scientific, Inc. | Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes |
US20090054513A1 (en) * | 2007-08-22 | 2009-02-26 | Response Scientific, Inc. | Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease |
DE102007051338A1 (de) * | 2007-10-26 | 2009-04-30 | Müller-Enoch, Dieter, Prof. Dr. | Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien |
NO20075894L (no) * | 2007-11-15 | 2009-05-18 | Thia Medica As | Redusert kjonnsmodning i fisk |
NO20081040L (no) * | 2008-02-27 | 2009-08-28 | Thia Medica As | Reduced HSMI mortality |
IT1397386B1 (it) * | 2010-01-12 | 2013-01-10 | Indena Spa | Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso. |
WO2012119781A2 (en) * | 2011-03-10 | 2012-09-13 | University Of Geneva | Novel lipids, phospholipids, phospholipid and lipid compositions and their use |
DE102011050519A1 (de) * | 2011-05-20 | 2012-11-22 | Universität Rostock | Alkylschwefelalkansäurederivate und ihre pharmazeutisch verträglichen Salze zur Behandlung chronisch entzündlicher Erkrankungen |
EP2540292A1 (en) * | 2011-06-28 | 2013-01-02 | Nestec S.A. | DHA and EPA in the reduction of oxidative stress |
PE20142459A1 (es) | 2012-01-06 | 2015-01-23 | Omthera Pharmaceuticals Inc | Composiciones enriquecidas con dpa de acidos grasos omega 3 poliinsaturados en forma de acido libre |
RU2539377C2 (ru) * | 2012-10-24 | 2015-01-20 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт общей патологии и патофизиологии" | Способ лечения атеросклероза, основанный на антицитокиновом действии |
WO2014140934A2 (en) | 2013-03-11 | 2014-09-18 | Life Science Nutrition As | Natural lipids containing non-oxidizable fatty acids |
EP2983658B1 (en) * | 2013-03-11 | 2024-05-01 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
US9763908B2 (en) * | 2013-09-03 | 2017-09-19 | Enzychem Lifesciences Corporation | Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating atopic dermatitis |
KR101644755B1 (ko) * | 2015-09-01 | 2016-08-01 | 경희대학교 산학협력단 | 뇌졸중 또는 퇴행성 뇌질환 예방 또는 치료용 조성물 |
US11058656B2 (en) * | 2015-11-25 | 2021-07-13 | Sciadonics, Inc. | Lipid formulations containing bioactive fatty acids |
CN106107192B (zh) * | 2016-06-23 | 2019-11-01 | 杭州康德权饲料有限公司 | 一种蛋禽饲料添加剂及其应用 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0198445A (ja) * | 1987-10-12 | 1989-04-17 | Kanebo Ltd | 経口摂食組成物 |
GB8813012D0 (en) * | 1988-06-02 | 1988-07-06 | Norsk Hydro As | Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals |
DE4304394A1 (en) * | 1993-02-13 | 1993-09-02 | Fresenius Ag | Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins |
NO952796D0 (no) * | 1995-07-14 | 1995-07-14 | Rolf Berge | Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater |
JP2829387B2 (ja) * | 1996-09-13 | 1998-11-25 | 農林水産省四国農業試験場長 | 脂肪細胞における脂肪分解促進用組成物 |
PT843972E (pt) * | 1996-11-20 | 2002-12-31 | Nutricia Nv | Composicao nutritiva que inclui gorduras para o tratamento do sindrome metabolico |
JP3408958B2 (ja) * | 1997-10-24 | 2003-05-19 | 旭化成株式会社 | 魚介類由来の有用物質を含む組成物およびその有用物質の製造方法 |
US6086353A (en) * | 1998-02-17 | 2000-07-11 | Cincinnati Milacron Inc. | Two-stage electric injection unit with rotating plunger |
AU7240398A (en) * | 1998-05-08 | 1999-11-29 | Rolf Berge | Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions |
JP2000104092A (ja) * | 1998-09-29 | 2000-04-11 | Nof Corp | 血清脂質改善油脂組成物 |
US6544566B1 (en) * | 1999-04-23 | 2003-04-08 | Protein Technologies International, Inc. | Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol |
AU2001231089A1 (en) * | 2000-01-21 | 2001-07-31 | Eatem Corporation | Complete meal formulation |
NO328926B1 (no) | 2000-03-03 | 2010-06-14 | Thia Medica As | Fettsyreanaloger og fremgangsmate for fremstilling av samme, samt et ernaeringsmateriale inneholdende fettsyrene, og anvendelse av fettsyreanalogene for forebygging eller behandling av sykdommer |
NO328803B1 (no) * | 2000-03-03 | 2010-05-18 | Thia Medica | Nye fettsyreanaloger |
NO20003591L (no) | 2000-07-13 | 2002-01-14 | Thia Medica As | Fettsyreanaloger for behandling av kreft |
JP4104814B2 (ja) * | 2000-09-22 | 2008-06-18 | 株式会社カネカ | 配合食用油脂 |
NO20004844L (no) * | 2000-09-27 | 2002-05-10 | Thia Medica As | Fettsyre analoger for behandling av proliferative hudsykdommer |
NO324555B1 (no) | 2000-09-27 | 2007-11-19 | Thia Medica As | Anvendelse av fettsyreanaloger for a hindre og/eller behandle proliferative hudsykdommer. |
NO324557B1 (no) | 2000-11-28 | 2007-11-19 | Thia Medica As | Anvendelse av fettsyreanaloger for a hindre og/eller behandle inflammatoriske og/eller autoimmune forstyrrelser. |
NO20006008L (no) * | 2000-11-28 | 2002-05-29 | Thia Medica As | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer |
CN1273608C (zh) * | 2001-02-09 | 2006-09-06 | 荷兰联合利华有限公司 | 通过发酵制备一种或多种抑制素的方法 |
FR2828487B1 (fr) * | 2001-08-09 | 2005-05-27 | Genfit S A | Nouveaux composes derives d'acides gras, preparation et utilisations |
JP4328058B2 (ja) * | 2002-04-12 | 2009-09-09 | 株式会社エイ・エル・エイ | 糖尿病合併症を予防する組成物 |
CA2490121C (en) | 2002-06-20 | 2013-01-08 | Ic Vec Limited | Modified phospholipids |
PE20040320A1 (es) * | 2002-08-14 | 2004-06-26 | Novozymes As | Composicion alimenticia que comprende hidrolizado de proteinas de pescado y metodo para obtenerla |
CA2507243A1 (en) * | 2002-11-26 | 2004-06-10 | Phares Pharmaceutical Research N.V. | Marine lipid compositions |
NO322425B1 (no) | 2003-07-04 | 2006-10-02 | Berge Biomed As | Anvendelse av et hydrolysat av proteinholdig fiskemateriale for fremstilling av et farmasoytisk middel for behandling og/eller hindring av patologisk hoye nivaer av tracylglyceroler, hyperkolesterolemia, hyperhomocysteinemia, eller patologisk lave nivaer av beta-oksidasjon i et dyr eller menneske. |
NO319551B1 (no) | 2003-07-04 | 2005-08-29 | Thia Medica As | Proteinmateriale fra enkeltceller |
EP1699447B1 (en) * | 2003-12-24 | 2008-09-03 | N.V. Nutricia | Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite |
-
2005
- 2005-07-19 EP EP05772070A patent/EP1773397A2/en not_active Withdrawn
- 2005-07-19 EP EP05772164A patent/EP1784223A2/en not_active Withdrawn
- 2005-07-19 CA CA002574366A patent/CA2574366A1/en not_active Abandoned
- 2005-07-19 JP JP2007522458A patent/JP2008506774A/ja active Pending
- 2005-07-19 EP EP10183765.6A patent/EP2275140B1/en active Active
- 2005-07-19 DK DK10183765.6T patent/DK2275140T3/en active
- 2005-07-19 WO PCT/NO2005/000271 patent/WO2006009464A2/en active Application Filing
- 2005-07-19 US US10/550,129 patent/US20070009608A1/en not_active Abandoned
- 2005-07-19 ES ES10183765.6T patent/ES2660700T3/es active Active
- 2005-07-19 CA CA2574381A patent/CA2574381C/en active Active
- 2005-07-19 NZ NZ553261A patent/NZ553261A/en not_active IP Right Cessation
- 2005-07-19 KR KR1020077003855A patent/KR20070046866A/ko not_active Application Discontinuation
- 2005-07-19 AU AU2005264782A patent/AU2005264782B2/en not_active Expired - Fee Related
- 2005-07-19 WO PCT/NO2005/000272 patent/WO2006009465A2/en active Application Filing
- 2005-07-19 AU AU2005264781A patent/AU2005264781B2/en not_active Ceased
- 2005-07-19 JP JP2007522457A patent/JP2008506773A/ja active Pending
- 2005-07-19 NZ NZ553260A patent/NZ553260A/en not_active IP Right Cessation
- 2005-07-19 KR KR1020077003854A patent/KR20070054637A/ko not_active Application Discontinuation
- 2005-07-19 MX MX2007000813A patent/MX2007000813A/es unknown
- 2005-07-19 US US10/550,033 patent/US7659242B2/en active Active
- 2005-07-19 MX MX2007000816A patent/MX2007000816A/es not_active Application Discontinuation
-
2007
- 2007-02-19 NO NO20070924A patent/NO20070924L/no not_active Application Discontinuation
- 2007-02-19 NO NO20070923A patent/NO20070923L/no not_active Application Discontinuation
- 2007-09-04 HK HK07109601.5A patent/HK1101555A1/xx not_active IP Right Cessation
-
2012
- 2012-03-19 US US13/423,884 patent/US20120276212A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK2275140T3 (en) | 2018-02-05 |
JP2008506774A (ja) | 2008-03-06 |
MX2007000813A (es) | 2007-06-05 |
KR20070046866A (ko) | 2007-05-03 |
NO20070924L (no) | 2007-04-19 |
CA2574366A1 (en) | 2006-01-26 |
NO20070923L (no) | 2007-04-19 |
US20070009608A1 (en) | 2007-01-11 |
AU2005264782B2 (en) | 2010-12-16 |
EP2275140A3 (en) | 2012-08-08 |
KR20070054637A (ko) | 2007-05-29 |
US20120276212A1 (en) | 2012-11-01 |
EP1784223A2 (en) | 2007-05-16 |
US20070015795A1 (en) | 2007-01-18 |
EP2275140B1 (en) | 2017-11-01 |
EP1773397A2 (en) | 2007-04-18 |
AU2005264781A1 (en) | 2006-01-26 |
CA2574381A1 (en) | 2006-01-26 |
AU2005264782A1 (en) | 2006-01-26 |
CA2574381C (en) | 2014-11-18 |
WO2006009465A2 (en) | 2006-01-26 |
JP2008506773A (ja) | 2008-03-06 |
WO2006009465A3 (en) | 2006-09-14 |
US7659242B2 (en) | 2010-02-09 |
NZ553260A (en) | 2010-12-24 |
NZ553261A (en) | 2010-12-24 |
EP2275140A2 (en) | 2011-01-19 |
MX2007000816A (es) | 2007-06-05 |
WO2006009464A2 (en) | 2006-01-26 |
AU2005264781B2 (en) | 2011-07-28 |
ES2660700T3 (es) | 2018-03-23 |
WO2006009464A3 (en) | 2006-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1101555A1 (en) | Composition comprising protein material and non-oxidizable fatty acid entities | |
Fan et al. | Marine algae-derived bioactive peptides for human nutrition and health | |
Zhai et al. | Crosslinking of decellularized porcine heart valve matrix by procyanidins | |
WO2000044882A8 (en) | Methods and compositions for the differentiation of human preadipocytes into adipocytes | |
PH12016502294A1 (en) | Novel fatty acids and their use in conjugation to biomolecules | |
DK1424074T3 (da) | Ernæringssammensætninger til regulering af blodglucoseniveau | |
WO2003007888A3 (en) | Fat accumulation-modulating compounds | |
WO2010084169A3 (en) | Fgf21 derivatives with albumin binder a-b-c-d-e- and their use | |
CO5621286A2 (es) | Combinacion de un inhibidor de dpp iv y un compuesto cardiovascular | |
AP2002002634A0 (en) | Malonamic Acids And Derivatives Thereof As Thyroid Receptor Ligands. | |
WO2002068650A3 (en) | Modified and stabilized gdf propeptides and uses thereof | |
WO2003057245A1 (fr) | Compositions servant a ameliorer le metabolisme lipidique | |
CN102292093A (zh) | 用于代谢综合症控制的选自绒毛戴星草和莽吉柿的混合物 | |
Liu et al. | Evaluation of antihypertensive and antihyperlipidemic effects of bamboo shoot angiotensin converting enzyme inhibitory peptide in vivo | |
WO2000043354A3 (en) | Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 | |
WO2004091495A3 (en) | Compositions and methods related to production of erythropoietin | |
WO2006127976A3 (en) | Compositions and their uses directed to ptpru | |
ATE486055T1 (de) | Neue verbindungen, ihre herstellung und verwendung | |
TW200513194A (en) | Fat and oil processed composition for prevention and/or amelioration of life-style related disease | |
EP2805951A3 (en) | Inhibitors of diacylglycerol o-acyltransferase 1 (DGAT-1) and uses thereof | |
WO1999061015A1 (fr) | Compositions destinees a diminuer l'activite mtp | |
GB0118300D0 (en) | Formulations | |
JP6496643B2 (ja) | 脳神経細胞増殖促進剤 | |
WO2007005774A3 (en) | Novel derivatives of amino acids for treatment of obesity and related disorders | |
KR101704381B1 (ko) | 에르고치오네인 함량이 증진된 느타리버섯 추출물의 제조방법 및 상기 방법으로 제조된 느타리버섯 추출물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180719 |